论文部分内容阅读
我们于1992年11月,在茶陵等11个县对333例10～26周不适于继续妊娠妇女,采用芫花萜膜终止妊娠。现将临床监测结果报道如下。 材料与方法 一、材料 芫花萜膜由河南开封中药制药厂和海南中祥制药有限公司各提供180人份。两家药厂剂量均为0.1lmg,并将两家药厂的药分别分组观察,由于效果差异级微,故将临床监测结果综合报道如下。 芫花萜膜主要为芫花酯甲,是以药膜树酯-04为基质制成的无菌膜剂,为白色或微黄色透明卷状
We in November 1992, Chaling and other 11 counties in 333 cases of 10 to 26 weeks is not suitable for the continuation of pregnant women, the use of genkwa terpene membrane termination of pregnancy. Clinical monitoring results are reported below. Materials and methods First, the material Yuanhua ternary membrane pharmaceutical companies in Henan Kaifeng and Hainan Zhongxiang Pharmaceutical Co., Ltd. to provide 180 people each. The dosage of the two pharmaceuticals are 0.1lmg, and the two pharmaceuticals were grouped under observation, the effect of micro-level difference, so the clinical monitoring results are reported as follows. The main constituents of Yuanhua is Avermectin A, which is a sterile film made of membrane-resin-04 as a base